Just one day after virologist Chris Barbara stated that Malta can see the arrival of the Covid vaccine next December, the vaccine has been put on hold due to suspected illness in a participant.

AstraZeneca’s Covid-19 vaccine has been put on hold due to a suspected serious adverse reaction in a participant in the UK.

A spokeperson from AstraZeneca first stated that the company’s “standard review process triggered a pause to vaccination to allow review of safety data.” Later that stated that the study is put on hold. And that the participant is expected to recover.

AstraZeneca is working with Oxford on the vaccine and was on phase 3 of testing (last phase) where it was testing on 30,000 people. Till this incident, things were looking very positive for the vaccine.

Malta already signed a contract for 330,000 doses from the company. And was set to get more doses afterwards.

The company described the pause as “a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.” However they are “working to expedite the review of the single event to minimise any potential impact on the trial timeline.”